Literature DB >> 7689933

c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.

H Plummer1, J Catlett, J Leftwich, B Armstrong, P Carlson, T Huff, G Krystal.   

Abstract

The mRNAs encoding the c-kit protooncogene tyrosine kinase receptor and its ligand, hemopoietic stem cell factor, are coexpressed in the majority of small cell lung cancer cell lines, suggesting that an autocrine growth loop may exist. Functional c-kit protein levels correspond well with mRNA levels in these cells. We have observed that those cell lines which express the c-kit gene also express either the L- and N-myc genes; those cell lines which express the c-myc gene do not express the c-kit gene. We have determined, by analyzing several small lung cancer cell lines transfected with a c-myc expression vector, that heterologous expression of c-myc correlates with a marked down-regulation of c-kit expression. Regulation of c-kit expression by the myc gene family may be partly responsible for the differing biological properties of cell lines and tumors which express N- and L-myc versus those that express c-myc.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689933

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Screening of the c-kit gene missense mutation in invasive ductal carcinoma of breast among north Indian population.

Authors:  Syed Rizwan Hussain; Sunil G Babu; Syed Tasleem Raza; Pradyumn Singh; Faisal Ahmed; Hena Naqvi; Farzana Mahdi
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

Review 2.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

3.  An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth.

Authors:  Toshihiko Tanno; Peng Zhang; Christopher A Lazarski; Yang Liu; Pan Zheng
Journal:  Blood Adv       Date:  2017-06-22

4.  Expression of c-kit and p53 in non-small cell lung cancers.

Authors:  Jinyoung Yoo; Chi Hong Kim; So Hyang Song; Byoung Yong Shim; Youn Ju Jeong; Meyung Im Ahn; Sung Whan Kim; Deog Gon Cho; Min Seop Jo; Kyu Do Cho; Hong Joo Cho; Hoon-Kyo Kim
Journal:  Cancer Res Treat       Date:  2004-06-30       Impact factor: 4.679

5.  Myc is an essential negative regulator of platelet-derived growth factor beta receptor expression.

Authors:  S K Oster; W W Marhin; C Asker; L M Facchini; P A Dion; K Funa; M Post; J M Sedivy; L Z Penn
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

6.  GATA-1-mediated proliferation arrest during erythroid maturation.

Authors:  Marcin Rylski; John J Welch; Ying-Yu Chen; Danielle L Letting; J Alan Diehl; Lewis A Chodosh; Gerd A Blobel; Mitchell J Weiss
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

7.  Identification of thymidylate synthase as a potential therapeutic target for lung cancer.

Authors:  K Takezawa; I Okamoto; S Tsukioka; J Uchida; M Kiniwa; M Fukuoka; K Nakagawa
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

8.  Small cell carcinomas of the lung express the Bcl-2 protein.

Authors:  J M Ben-Ezra; M J Kornstein; M M Grimes; G Krystal
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

9.  Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.

Authors:  Howard K Plummer; Madhu S Dhar; Maria Cekanova; Hildegard M Schuller
Journal:  BMC Cancer       Date:  2005-08-18       Impact factor: 4.430

10.  Markers of small cell lung cancer.

Authors:  Tarvinder K Taneja; S K Sharma
Journal:  World J Surg Oncol       Date:  2004-05-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.